SG/CALL/ABBOTT LABORATORIES/130/0.1/21.03.25 Stock

Warrant

DE000SW3PQ19

Delayed Deutsche Boerse AG 10:46:59 2024-05-20 EDT
0.15 EUR -6.25% Intraday chart for SG/CALL/ABBOTT LABORATORIES/130/0.1/21.03.25
Current month-38.46%
1 month-46.67%
Date Price Change
24-05-20 0.15 -6.25%
24-05-17 0.16 -5.88%
24-05-16 0.17 -5.56%
24-05-15 0.18 +5.88%
24-05-14 0.17 -10.53%

Delayed Quote Deutsche Boerse AG

Last update May 20, 2024 at 10:46 am

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
IssuerLogo Issuer Société Générale Société Générale
WKN SW3PQ1
ISINDE000SW3PQ19
Date issued 2023-09-19
Strike 130 $
Maturity 2025-03-21 (305 Days)
Parity 10 : 1
Emission price 0.42
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.89
Lowest since issue 0.15
Spread 0.01
Spread %6.25%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.1 USD
Average target price
126.1 USD
Spread / Average Target
+21.19%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW